REDWOOD CITY, CA--(Marketwire - December 09, 2008) - PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) announced today that the Securities and Exchange Commission (SEC) has declared effective the Form 10 registration statement filed by PDL's wholly owned subsidiary, Facet Biotech Corporation.
